(Q38779981)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

title

BET inhibition represses miR17-92 to drive BIM-initiated apoptosis of normal and transformed hematopoietic cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Brandon J Aubrey

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Marco J Herold

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Andreas Strasser

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Andrew W. Roberts

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Christopher J. Burns

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

David C Huang

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

author name string

Z Xu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

Y Yao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

D Segal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

C H Ang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

S L Khaw

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

J Gong

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

G L Kelly

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

W S Alexander

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

S P Glaser

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

language of work or name

1 reference

8 March 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

31 March 2020

page(s)

1531-1541

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27055867%20AND%20SRC:MED&resulttype=core&format=json

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

31 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Targeting MYC dependence in cancer by inhibiting BET bromodomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

BET bromodomain inhibition as a therapeutic strategy to target c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Inhibition of bromodomain proteins for the treatment of human diffuse large B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

The mechanisms behind the therapeutic activity of BET bromodomain inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Histone recognition and large-scale structural analysis of the human bromodomain family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

BET domain co-regulators in obesity, inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Selective inhibition of BET bromodomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

The Bcl-2-regulated apoptotic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

The BCL-2 protein family: opposing activities that mediate cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Apoptosis: a link between cancer genetics and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Cancer drug resistance: an evolving paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Decoding and unlocking the BCL-2 dependency of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Reprogramming of human somatic cells to pluripotency with defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Polycystic kidney disease prevented by transgenic RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Enforced expression of the homeobox gene Mixl1 impairs hematopoietic differentiation and results in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

An inducible lentiviral guide RNA platform enables the identification of tumor-essential genes and tumor-promoting mutations in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

The BH3-Only Protein Bid Is Dispensable for DNA Damage- and Replicative Stress-Induced Apoptosis or Cell-Cycle Arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Tumor spectrum analysis in p53-mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Both leukaemic and normal peripheral B lymphoid cells are highly sensitive to the selective pharmacological inhibition of prosurvival Bcl-2 with ABT-199.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Live or let die: the cell's response to p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Caspases: intracellular signaling by proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Brd4 and JMJD6-associated anti-pause enhancers in regulation of transcriptional pause release

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Selective inhibition of tumor oncogenes by disruption of super-enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

BET bromodomain inhibition of MYC-amplified medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

BET bromodomain inhibition triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors through Bim induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Chromatin poises miRNA- and protein-coding genes for expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

c-Myc-regulated microRNAs modulate E2F1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Tumorigenicity of the miR-17-92 cluster distilled

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

The landscape of somatic copy-number alteration across human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

Inducible in vivo silencing of Brd4 identifies potential toxicities of sustained BET protein inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.52

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FLEU.2016.52

21 January 2018

12 December 2020

The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic mice

2 references

https://api.crossref.org/works/10.1038%2FLEU.2016.52

21 January 2018

12 December 2020

BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma

1 reference

PubMed

12 December 2020

Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis

1 reference

PubMed

12 December 2020